(INNS)
TAMGIBLIMAB(INND)
TAMGIBLIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-448) [VH (HOMO SAPIENS IGHV1-46*01 (95.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.15] (26-33.51-58.97-111)) (1-122)-HOMO SAPIENS IGHG4*01, G4V5 H P10, G4V4 CH2 A1.3, A1.2 (CH1 (123-220), HINGE 1-12 S10>P (230) (221-232), CH2 F1.3>A (236), L1.2>A (237) (233-342), CH3 (343-447), CHS K2>DEL (448)) (123-448)], (136-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-12*01 (95.8%) -IGKJ4*01 (91.7%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (228- 228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GSKO), GLYCOFORM ALFA(WHO)
TAMGIBLIMABUM(INN)